UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 44

of 'General principles of neoadjuvant therapy for breast cancer'

44
TI
Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: outcomes from CALGB 40603 (Alliance).
AU
Sikov WM, Berry DA, Perou CM, et al
SO
SABCS . 2015;abstract S2-05
 
AD